Advertisement

Topics

Sanofi Genzyme Company Profile

15:07 EDT 20th June 2019 | BioPortfolio

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.


News Articles [808 Associated News Articles listed on BioPortfolio]

Sanofi Q1 growth driven by Genzyme

Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling. Net sales were €8,391 million, an increase...

STAT Plus: With real estate deal, Sanofi Genzyme boosts its bottom line in hot market

Sanofi Genzyme makes most of its money developing complicated drugs for rare diseases. But for the next decade it will profit in a simpler way: by flipping its real estate.

STAT Plus: Sanofi-Genzyme inappropriately sought confidential patient information, suit alleges

A former Sanofi-Genzyme employee is accusing the company of inappropriately seeking confidential patient information, as part of a lawsuit alleging wrongful termination.

STAT Plus: Sanofi-Genzyme inappropriately sought confidential patient information, former employee’s wrongful termination suit alleges

A former Sanofi-Genzyme employee is accusing the company of inappropriately seeking confidential patient information, as part of a lawsuit alleging wrongful termination.

Voyager Revises Sanofi Deal, Shifts Some Assets

“Our alliance with Sanofi Genzyme has been foundational for Voyager as we optimized the development of capsids, transgenes and gene therapy delivery,” stated Andre Turenne, president and chief exe...

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Specialist drugs are growth engines in Q1

Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update

Gains worldwide rights to VY-HTT01 for Huntington’s disease Resources to be reallocated to VY-HTT01 and other programs; intends to seek a partner for the SOD1 ALS program CAMBRIDGE, Mass., June ...

Sanofi extends growth spurt thanks to Genzyme, Dupixent

US approval of Cablivi adds to good news

Drugs and Medications [56 Associated Drugs and Medications listed on BioPortfolio]

Renvela [genzyme corporation]

These highlights do not include all the information needed to use Renvela safely and effectively. See full prescribing information for Renvela. Renvela (sevelamer carbonate) Tablet, Film Coated for Or...

Renagel [genzyme corporation]

These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use In...

Avalide [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE (irbesartan and hydrochlorothiazide) tablets, fo...

Methenamine hippurate [winthrop u.s.]

METHENAMINE HIPPURATE TABLETS, USP

Taxotere [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) injection, for intravenous use In...

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Mobilization of leukemic cells using plerixafor as part of a myeloablative preparative regimen for patients with AML undergoing allografting: assessment of safety and tolerability.

Allogeneic hematopoietic cell transplantation (HCT) is potentially curative for acute myeloid leukemia (AML), however a major cause for treatment failure is disease relapse. The purpose of this single...

Fexinidazole: First Global Approval.

Fexinidazole Winthrop (hereafter referred to as fexinidazole) is a DNA synthesis inhibitor developed by the Drugs for Neglected Diseases initiative (DNDi), in collaboration with Sanofi, for the oral t...

ICER Can Do Better for Patients.

No outside funding supported the writing of this article. Mendez is president and CEO of the Asthma and Allergy Foundation of America, which receives greater than 25% of its funding to produce educati...

Dengue Vaccine Development: Global and Indian Scenarios.

India is home to nearly a third of the global population at risk of dengue, a viral disease caused by four antigenically and genetically distinct dengue viruses. Clinical illness following dengue viru...

The development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series.

Dupilumab (Dupixent , Sanofi), a fully human monoclonal antibody that blocks interleukin (IL)-4 and IL-13 signaling, is the first biologic approved in the UK for adult patients with moderate-to-severe...

Clinical Trials [96 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

The purpose of this study is to determine the safety and efficacy of Busulfan/FLAG (fludarabine, cytarabine and granulocyte colony-stimulating factor) Conditioning Regimen in Patients with...

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approve...

Extension Study of Long-Term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

This extension study was to monitor the long-term safety and efficacy of rhGAA treatment in a single patient with infantile-onset Pompe disease who were previously treated with rhGAA in a ...

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Companies [83 Associated Companies listed on BioPortfolio]

Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals t...

Sanofi and Warp Drive Bio

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human va...

SANOFI

SANOFI concentrate their research efforts where the most pressing medical needs and public health issues are, bringing solutions to patients and contributing to a healthier society worldwide: D...

Sanofi Genzyme

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, prov...

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. San...

More Information about "Sanofi Genzyme" on BioPortfolio

We have published hundreds of Sanofi Genzyme news stories on BioPortfolio along with dozens of Sanofi Genzyme Clinical Trials and PubMed Articles about Sanofi Genzyme for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi Genzyme Companies in our database. You can also find out about relevant Sanofi Genzyme Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record